GEOFFREY P KLINE

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease FORT WORTH, TX NPI 1497977490

General Payments — all program years on this page

$4,655.10

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 217
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $420.32 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $420.3216

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,616.1683
2019 $1,289.4155
2020 $398.3916
2021 $251.5913
2022 $385.2720
2023 $293.9614
2024 $420.3216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078916197 Actelion Pharmaceuticals US, Inc. $25.48 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078916223 Actelion Pharmaceuticals US, Inc. $25.48 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078916263 Actelion Pharmaceuticals US, Inc. $24.07 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087052694 Novartis Pharmaceuticals Corporation $23.09 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087052710 Novartis Pharmaceuticals Corporation $31.96 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087052720 Novartis Pharmaceuticals Corporation $31.88 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092611626 Boston Scientific Corporation $43.30 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092611628 Boston Scientific Corporation $44.82 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104434321 AstraZeneca Pharmaceuticals LP $17.11 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104559702 AstraZeneca Pharmaceuticals LP $13.69 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104560942 AstraZeneca Pharmaceuticals LP $16.86 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111621484 Amgen Inc. $31.49 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111621486 Amgen Inc. $16.22 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111621488 Amgen Inc. $23.62 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153620137 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.90 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154874278 Kiniksa Pharmaceuticals International, plc $29.35 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.